Who makes [F-18]RGD-K5?

[F-18]RGD-K5 is developed by Siemens Molecular Imaging.

Last reviewed 2026-04-19 · How we verify

[F-18]RGD-K5

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Siemens Molecular Imaging · Phase 2 active Small molecule

At a glance

Generic name	[F-18]RGD-K5
Sponsor	Siemens Molecular Imaging
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[F-18]RGD-K5 CI brief — competitive landscape report
[F-18]RGD-K5 updates RSS · CI watch RSS
Siemens Molecular Imaging portfolio CI